Finance

Beta
Lists
PCRX:CVE
PharmaCorp Rx Inc
CA$0.54
+3.85%
(+0.020) 1D
Jun 3, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for PCRX...
Open
CA$0.53
High
CA$0.55
Low
CA$0.51
Mkt. cap
94.00M
Avg. vol.
158.52K
Volume
104.67K
52-wk high
CA$0.58
52-wk low
CA$0.40
EPS
-CA$0.01
Beta
1.12
Shares outstanding
172.84M
Open
CA$0.53
High
CA$0.55
Low
CA$0.51
Mkt. cap
94.00M
Avg. vol.
158.52K
Volume
104.67K
52-wk high
CA$0.58
52-wk low
CA$0.40
EPS
-CA$0.01
Beta
1.12
Shares outstanding
172.84M
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to PCRX in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for PCRX in the last 3 months.
Highest
Current CA$0.54
CA$0.70 (+29.63%)
Average
CA$0.70 (+29.63%)
Lowest
CA$0.70 (+29.63%)
News stories
From sources across the web
About PharmaCorp Rx Inc
CEO-
Employees-
Founded2021
HeadquartersSaskatoon, Saskatchewan, Canada
SectorDrug
Websitepharmacorprx.ca
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.40M
4.80M
7.69M
7.19M
Cost of goods sold
2.65M
2.84M
4.72M
4.40M
Cost of revenue
2.65M
2.84M
4.72M
4.40M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.89M
2.03M
3.06M
2.44M
Operating expense
2.08M
2.46M
3.60M
2.84M
Total operating expenses
4.73M
5.30M
8.33M
7.24M
Operating income
-330.68K
-498.82K
-636.36K
-51.28K
Other non operating income
32.74K
34.36K
54.46K
45.66K
EBT including unusual items
-227.77K
-428.08K
-541.98K
118.47K
EBT excluding unusual items
-227.77K
-428.08K
-541.98K
118.47K
Income tax expense
157.96K
-18.90K
339.47K
-8.48K
Effective tax rate
-69.35%
4.42%
-62.64%
-7.16%
Other operating expenses
-
-
-
-
Net income
-384.07K
-427.52K
-911.69K
108.20K
Net profit margin
-8.74%
-8.90%
-11.86%
1.51%
Earnings per share
-
-
-
-
Interest and investment income
83.42K
56.18K
50.03K
159.24K
Interest expense
-13.24K
-19.80K
-10.11K
-35.14K
Net interest expenses
70.17K
36.38K
39.92K
124.10K
Depreciation and amortization charges
188.64K
222.33K
341.77K
352.35K
EBITDA
-164.48K
-301.88K
-341.57K
301.06K
Gain or loss from assets sale
-
-
-
-203.00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer